BRISTOL-MYERS SQUIBB COMPANY Increase (Decrease) in Other Operating Assets and Liabilities, Net
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $850.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-06-30 was -$786.00M.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was $1.64B, a 54.49% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was -$1.07B.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was -$240.00M.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was -$471.00M.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was -$624.00M, a 193.55% decline from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was $667.00M, a 9.34% increase from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was $610.00M, a 130.19% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$786.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $850.00M 10-Q · filed 2026-07-30 | -$218.00M derived: sum of 3 quarters · filed 2026-07-30 | -$458.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $1.64B 10-Q · filed 2026-04-30 | $568.00M derived: sum of 2 quarters · filed 2026-04-30 | $328.00M derived: sum of 3 quarters · filed 2026-04-30 | $106.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$1.31B derived: sum of 2 quarters · filed 2026-02-11 | -$1.53B derived: sum of 3 quarters · filed 2026-07-30 | -$471.00M 10-K · filed 2026-02-11 | ||||
| 2025-09-30 | -$240.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$462.00M derived: sum of 2 quarters · filed 2026-07-30 | $597.00M 10-Q · filed 2025-10-30 | -$128.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$222.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $837.00M 10-Q · filed 2026-07-30 | $112.00M derived: sum of 3 quarters · filed 2026-07-30 | -$55.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $1.06B 10-Q · filed 2026-04-30 | $334.00M derived: sum of 2 quarters · filed 2026-04-30 | $167.00M derived: sum of 3 quarters · filed 2026-04-30 | -$173.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | -$725.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$892.00M derived: sum of 2 quarters · filed 2026-02-11 | -$1.23B derived: sum of 3 quarters · filed 2026-02-11 | -$624.00M 10-K · filed 2026-02-11 | ||||
| 2024-09-30 | -$167.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$507.00M derived: sum of 2 quarters · filed 2025-10-30 | $101.00M 10-Q · filed 2025-10-30 | -$182.00M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-06-30 | -$340.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $268.00M 10-Q · filed 2025-07-31 | -$15.00M derived: sum of 3 quarters · filed 2026-02-11 | $44.00M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | $608.00M 10-Q · filed 2025-04-24 | $325.00M derived: sum of 2 quarters · filed 2026-02-11 | $384.00M derived: sum of 3 quarters · filed 2026-02-11 | $211.00M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | -$283.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$224.00M derived: sum of 2 quarters · filed 2026-02-11 | -$397.00M derived: sum of 3 quarters · filed 2026-02-11 | $667.00M 10-K · filed 2026-02-11 | ||||
| 2023-09-30 | $59.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$114.00M derived: sum of 2 quarters · filed 2024-10-31 | $950.00M 10-Q · filed 2024-10-31 | $250.00M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | -$173.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $891.00M 10-Q · filed 2024-07-26 | $191.00M derived: sum of 3 quarters · filed 2025-02-12 | $237.00M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $1.06B 10-Q · filed 2024-04-25 | $364.00M derived: sum of 2 quarters · filed 2025-02-12 | $410.00M derived: sum of 3 quarters · filed 2025-02-12 | $601.00M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | -$700.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$654.00M derived: sum of 2 quarters · filed 2025-02-12 | -$463.00M derived: sum of 3 quarters · filed 2025-02-12 | $610.00M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $46.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $237.00M derived: sum of 2 quarters · filed 2023-10-26 | $1.31B 10-Q · filed 2023-10-26 | $1.04B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-06-30 | $191.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $1.26B 10-Q · filed 2023-07-27 | $992.00M derived: sum of 3 quarters · filed 2024-02-13 | $836.00M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-03-31 | $1.07B 10-Q · filed 2023-04-27 | $801.00M derived: sum of 2 quarters · filed 2024-02-13 | $645.00M derived: sum of 3 quarters · filed 2024-02-13 | $421.00M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2021-12-31 | -$272.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$428.00M derived: sum of 2 quarters · filed 2024-02-13 | -$652.00M derived: sum of 3 quarters · filed 2024-02-13 | $265.00M 10-K · filed 2024-02-13 | $257.00M 10-K · filed 2022-02-09 | |||
| 2021-09-30 | -$156.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | -$380.00M derived: sum of 2 quarters · filed 2022-10-26 | $537.00M 10-Q · filed 2022-10-26 | -$370.00M 10-Q · filed 2021-10-27 | $1.61B derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-06-30 | -$224.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $693.00M 10-Q · filed 2022-07-27 | $695.00M 10-Q · filed 2021-07-28 | $1.76B derived: sum of 3 quarters · filed 2023-02-14 | $675.00M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-03-31 | $917.00M 10-Q · filed 2022-04-29 | $1.14B 10-Q · filed 2021-04-29 | $1.99B derived: sum of 2 quarters · filed 2023-02-14 | $899.00M derived: sum of 3 quarters · filed 2023-02-14 | $670.00M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2020-12-31 | $1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$18.00M derived: sum of 2 quarters · filed 2023-02-14 | -$247.00M derived: sum of 3 quarters · filed 2023-02-14 | $111.00M 10-K · filed 2023-02-14 | -$1.07B 10-K · filed 2021-02-10 | |||
| 2020-09-30 | -$1.09B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$1.32B derived: sum of 2 quarters · filed 2021-10-27 | -$960.00M 10-Q · filed 2021-10-27 | -$970.00M 10-Q · filed 2020-11-05 | -$490.00M derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-06-30 | -$229.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $129.00M 10-Q · filed 2021-07-28 | $135.00M 10-Q · filed 2020-08-06 | $599.00M derived: sum of 3 quarters · filed 2022-02-09 | -$304.00M derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-03-31 | $358.00M 10-Q · filed 2021-04-29 | $355.00M 10-Q · filed 2020-05-07 | $828.00M derived: sum of 2 quarters · filed 2022-02-09 | -$75.00M derived: sum of 3 quarters · filed 2022-02-09 | -$787.00M derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2019-12-31 | $470.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | -$433.00M derived: sum of 2 quarters · filed 2022-02-09 | -$1.15B derived: sum of 3 quarters · filed 2022-02-09 | -$228.00M 10-K · filed 2022-02-09 | -$702.00M 10-K · filed 2020-02-24 | |||
| 2019-09-30 | -$903.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$1.61B derived: sum of 2 quarters · filed 2020-11-05 | -$698.00M 10-Q · filed 2020-11-05 | -$685.00M 10-Q · filed 2019-10-31 | -$1.61B derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2019-06-30 | -$712.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $205.00M 10-Q · filed 2020-08-06 | $214.00M 10-Q · filed 2019-07-25 | -$705.00M derived: sum of 3 quarters · filed 2021-02-10 | -$834.00M derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2019-03-31 | $917.00M 10-Q · filed 2020-05-07 | $932.00M 10-Q · filed 2019-04-25 | $7.00M derived: sum of 2 quarters · filed 2021-02-10 | -$122.00M derived: sum of 3 quarters · filed 2021-02-10 | -$496.00M derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2018-12-31 | -$910.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | -$1.04B derived: sum of 2 quarters · filed 2021-02-10 | -$1.41B derived: sum of 3 quarters · filed 2021-02-10 | -$718.00M 10-K · filed 2021-02-10 | -$634.00M 10-K · filed 2019-02-25 | |||
| 2018-09-30 | -$129.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$503.00M derived: sum of 2 quarters · filed 2019-10-31 | $192.00M 10-Q · filed 2019-10-31 | -$34.00M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | -$374.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $321.00M 10-Q · filed 2019-07-25 | $95.00M derived: sum of 3 quarters · filed 2020-02-24 | -$59.00M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $695.00M 10-Q · filed 2019-04-25 | $469.00M derived: sum of 2 quarters · filed 2020-02-24 | $315.00M derived: sum of 3 quarters · filed 2020-02-24 | $145.00M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | -$226.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$380.00M derived: sum of 2 quarters · filed 2020-02-24 | -$550.00M derived: sum of 3 quarters · filed 2020-02-24 | $227.00M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | -$154.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | -$324.00M derived: sum of 2 quarters · filed 2018-10-25 | $453.00M 10-Q · filed 2018-10-25 | -$116.00M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | -$170.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $607.00M 10-Q · filed 2018-07-26 | $38.00M derived: sum of 3 quarters · filed 2019-02-25 | $8.00M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $777.00M 10-Q · filed 2018-04-26 | $208.00M derived: sum of 2 quarters · filed 2019-02-25 | $178.00M derived: sum of 3 quarters · filed 2019-02-25 | -$122.00M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | -$569.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | -$599.00M derived: sum of 2 quarters · filed 2019-02-25 | -$899.00M derived: sum of 3 quarters · filed 2019-02-25 | -$216.00M 10-K · filed 2019-02-25 | -$100.00M 10-K · filed 2017-02-21 | |||
| 2016-09-30 | -$30.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$330.00M derived: sum of 2 quarters · filed 2017-10-26 | $353.00M 10-Q · filed 2017-10-26 | $467.00M 10-Q · filed 2016-10-27 | -$479.00M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-06-30 | -$300.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $383.00M 10-Q · filed 2017-07-27 | $496.00M 10-Q · filed 2016-07-28 | -$449.00M derived: sum of 3 quarters · filed 2018-02-13 | -$758.00M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-03-31 | $683.00M 10-Q · filed 2017-04-27 | $794.00M 10-Q · filed 2016-04-28 | -$149.00M derived: sum of 2 quarters · filed 2018-02-13 | -$458.00M derived: sum of 3 quarters · filed 2018-02-13 | -$758.00M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2015-12-31 | -$832.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$1.14B derived: sum of 2 quarters · filed 2018-02-13 | -$1.44B derived: sum of 3 quarters · filed 2018-02-13 | -$617.00M 10-K · filed 2018-02-13 | -$471.00M 10-K · filed 2016-02-12 | |||
| 2015-09-30 | -$309.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | -$609.00M derived: sum of 2 quarters · filed 2016-10-27 | $215.00M 10-Q · filed 2016-10-27 | $233.00M 10-Q · filed 2015-10-27 | -$105.00M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-06-30 | -$300.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $524.00M 10-Q · filed 2016-07-28 | $538.00M 10-Q · filed 2015-07-23 | $204.00M derived: sum of 3 quarters · filed 2017-02-21 | $177.00M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-03-31 | $824.00M 10-Q · filed 2016-04-28 | $832.00M 10-Q · filed 2015-04-28 | $504.00M derived: sum of 2 quarters · filed 2017-02-21 | $477.00M derived: sum of 3 quarters · filed 2017-02-21 | $272.00M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2014-12-31 | -$320.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | -$347.00M derived: sum of 2 quarters · filed 2017-02-21 | -$552.00M derived: sum of 3 quarters · filed 2017-02-21 | -$8.00M 10-K · filed 2017-02-21 | $33.00M 10-K · filed 2015-02-13 | |||
| 2014-09-30 | -$27.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | -$232.00M derived: sum of 2 quarters · filed 2015-10-27 | $312.00M 10-Q · filed 2015-10-27 | $16.00M 10-Q · filed 2014-10-24 | $502.00M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-06-30 | -$205.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | $339.00M 10-Q · filed 2015-07-23 | $156.00M 10-Q · filed 2014-07-24 | $529.00M derived: sum of 3 quarters · filed 2016-02-12 | $667.00M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-03-31 | $544.00M 10-Q · filed 2015-04-28 | $350.00M 10-Q · filed 2014-04-29 | $734.00M derived: sum of 2 quarters · filed 2016-02-12 | $872.00M derived: sum of 3 quarters · filed 2016-02-12 | $429.00M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2013-12-31 | $190.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $328.00M derived: sum of 2 quarters · filed 2016-02-12 | -$115.00M derived: sum of 3 quarters · filed 2016-02-12 | $760.00M 10-K · filed 2016-02-12 | $466.00M 10-K · filed 2014-02-14 | |||
| 2013-09-30 | $138.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | -$305.00M derived: sum of 2 quarters · filed 2014-10-24 | $570.00M 10-Q · filed 2014-10-24 | $898.00M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | -$443.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $432.00M 10-Q · filed 2014-07-24 | $760.00M derived: sum of 3 quarters · filed 2015-02-13 | $376.00M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | $875.00M 10-Q · filed 2014-04-29 | $1.20B derived: sum of 2 quarters · filed 2015-02-13 | $819.00M derived: sum of 3 quarters · filed 2015-02-13 | $1.07B derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $328.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$56.00M derived: sum of 2 quarters · filed 2015-02-13 | $192.00M derived: sum of 3 quarters · filed 2015-02-13 | $1.19B 10-K · filed 2015-02-13 | $897.00M 10-K · filed 2013-02-15 | |||
| 2012-09-30 | -$384.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | -$136.00M derived: sum of 2 quarters · filed 2013-10-23 | $861.00M 10-Q · filed 2013-10-23 | $589.00M derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2012-06-30 | $248.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $1.25B 10-Q · filed 2013-07-25 | $973.00M derived: sum of 3 quarters · filed 2014-02-14 | $744.00M derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2012-03-31 | $997.00M 10-Q · filed 2013-04-25 | $995.00M 10-Q · filed 2012-04-26 | $725.00M derived: sum of 2 quarters · filed 2014-02-14 | $496.00M derived: sum of 3 quarters · filed 2014-02-14 | $481.00M derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2011-12-31 | -$272.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | -$501.00M derived: sum of 2 quarters · filed 2014-02-14 | -$516.00M derived: sum of 3 quarters · filed 2014-02-14 | $58.00M 10-K · filed 2014-02-14 | ||||
| 2011-09-30 | -$229.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | -$244.00M derived: sum of 2 quarters · filed 2012-10-24 | $330.00M 10-Q · filed 2012-10-24 | $161.00M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-06-30 | -$15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $559.00M 10-Q · filed 2012-07-25 | $390.00M derived: sum of 3 quarters · filed 2013-02-15 | $68.00M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-03-31 | $574.00M 10-Q · filed 2012-04-26 | $405.00M derived: sum of 2 quarters · filed 2013-02-15 | $83.00M derived: sum of 3 quarters · filed 2013-02-15 | $265.00M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2010-12-31 | -$169.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | -$491.00M derived: sum of 2 quarters · filed 2013-02-15 | -$309.00M derived: sum of 3 quarters · filed 2013-02-15 | $248.00M 10-K · filed 2013-02-15 | -$248.00M 10-K · filed 2011-02-18 | |||
| 2010-09-30 | -$322.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$140.00M derived: sum of 2 quarters · filed 2011-10-27 | $417.00M 10-Q · filed 2011-10-27 | -$417.00M 10-Q · filed 2010-10-26 | $2.43B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-06-30 | $182.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $739.00M 10-Q · filed 2011-07-28 | -$739.00M 10-Q · filed 2010-07-22 | $2.75B derived: sum of 3 quarters · filed 2012-02-17 | $2.97B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-03-31 | $557.00M 10-Q · filed 2011-04-28 | $2.57B derived: sum of 2 quarters · filed 2012-02-17 | $2.78B derived: sum of 3 quarters · filed 2012-02-17 | $744.00M derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2009-12-31 | $2.02B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $2.23B derived: sum of 2 quarters · filed 2012-02-17 | $187.00M derived: sum of 3 quarters · filed 2012-02-17 | $932.00M 10-K · filed 2012-02-17 | ||||
| 2009-09-30 | $211.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | -$1.83B derived: sum of 2 quarters · filed 2010-10-26 | -$1.08B 10-Q · filed 2010-10-26 | $1.07B 10-Q · filed 2009-10-22 | -$1.60B derived: sum of 4 quarters · filed 2011-02-18 | |||
| 2009-06-30 | -$2.04B derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-22 | -$1.29B 10-Q · filed 2010-07-22 | $1.28B 10-Q · filed 2009-07-23 | -$1.81B derived: sum of 3 quarters · filed 2011-02-18 | -$2.12B derived: sum of 4 quarters · filed 2011-02-18 | |||
| 2009-03-31 | $745.00M 10-Q · filed 2010-04-29 | $229.00M derived: sum of 2 quarters · filed 2011-02-18 | -$80.00M derived: sum of 3 quarters · filed 2011-02-18 | |||||
| 2008-12-31 | -$516.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | -$825.00M derived: sum of 2 quarters · filed 2011-02-18 | -$338.00M 10-K · filed 2011-02-18 | $338.00M 10-K · filed 2010-02-19 | ||||
| 2008-09-30 | -$309.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | $178.00M 10-Q · filed 2009-10-22 | ||||||
| 2008-06-30 | $487.00M 10-Q · filed 2009-07-23 | |||||||
| 2007-12-31 | -$109.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |